2 sectors that could outperform the ASX 200 in 2026

With AI reshaping industries and medical innovation advancing at record speed, Technology and Healthcare are two sectors built on innovation that could outperform the ASX 200 in 2026.

 Technology sector 

The technology sector looks interesting as AI, automation and cloud are now growing fast across different industries and tech firms with steady recurring income models which also have competitive advantages like network effects and low Capital Expenditure requirements are likely to do better than the wider market. Government push for innovation and higher need for cybersecurity and data analytics has helped this sector as well. As more global companies spend on digital transformation, technology companies will enter a new growth cycle and the following well managed ASX technology companies can capitalise on this growth.

Technology One Limited (ASX: TNE) 

has created an edge in Australia’s enterprise tech space with it’s all in one SaaS platform which brings in steady recurring income and is on the right track to realize it’s aim to double its size every five years.

NEXTDC Limited (ASX: NXT) 

continues to strengthen its position as Australia’s premier data centre operator, leveraging the global AI and cloud boom through long term contracts and massive scalability that positions it to be a core player in digital infrastructure.

Xero Limited (ASX: XRO) 

has an ideal cloud based accounting and payroll ecosystem which has high switching costs and deep customer integration, positioning it for long term growth as small businesses worldwide accelerate their digital transformation.

Healthcare Sector 

The healthcare sector looks promising as it gives investors a good mix of stability and growth due to ageing population and a rising number of chronic diseases. Australia’s over 65 population is growing fast which is increasing spending on treatments, biotech and social help services. This is not a short-term requirement but a long-term opportunity that will continue for years to come. ASX healthcare companies are now becoming global with pricing power and steady income even when markets are unstable. In 2026 the mix of cash flows and innovation in areas like gene therapy, medical devices and digital health is expected to push growth further. The following ASX healthcare companies are well positioned to capitalise on this growth trend.

CSL Limited (ASX: CSL) 

is a global healthcare leader with a moat built on its world class plasma therapies, vaccines and its upcoming demerger of CSL Seqirus is set to unlock further value by creating focus and driving innovation across both businesses.

ResMed Inc (ASX: RMD) 

has made a name for itself with its sleep and breathing care products. It combines AI-powered devices with cloud software that helps millions of people handle long term health issues from home. This is smart and scalable as more people and hospitals start using digital healthcare around the world, giving the company a strong base for growth in coming years.

Cochlear Limited (ASX: COH) 

is a global leader in hearing implants with its focus on innovation and long lasting products which sets it up for steady growth as more people get aware and access hearing solutions across the world.

(Source: Company Reports)